Opseu Pension Plan Trust Fund Neurocrine Biosciences Inc Transaction History

Opseu Pension Plan Trust Fund

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$89.43 - $102.27 $677,521 - $774,797	-7,576 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$87.57 - $119.4 $21,542 - $29,372	246 Added 3.36%	7,576 $737,000
Q4 2020 Feb 11, 2021	SELL	$86.91 - $108.33 $147,573 - $183,944	-1,698 Reduced 18.81%	7,330 $699,000
Q3 2020 Nov 09, 2020	SELL	$96.16 - $135.15 $7,692 - $10,812	-80 Reduced 0.88%	9,028 $855,000
Q2 2020 Aug 10, 2020	BUY	$85.09 - $130.36 $774,999 - $1.19 Million	9,108 New	9,108 $1.14 Million

627

94.3M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12.2B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Opseu Pension Plan Trust Fund, based on Form 13F filings with the SEC.

Stay updated on Opseu Pension Plan Trust Fund with notifications on news.